|
Volumn 135, Issue 2, 2010, Pages 80-83
|
Applications of PET imaging in the preclinical stage of drug development
|
Author keywords
[No Author keywords available]
|
Indexed keywords
1,2,3,5,6,10B HEXAHYDRO 6 (4 METHYLTHIOPHENYL)PYRROLO[2,1 A]ISOQUINOLINE;
1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE;
5 (7 BENZOFURANYL) 8 CHLORO 2,3,4,5 TETRAHYDRO 7 HYDROXY 3 METHYL 1H 3 BENZAZEPINE;
8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE;
AROMATIC LEVO AMINO ACID DECARBOXYLASE;
CHOLINESTERASE INHIBITOR;
CYCLIC AMP;
FLUORINE 18;
LEVODOPA;
N (4 ACETYL 1 PIPERAZINYL) 4 FLUOROBENZAMIDE;
N METHYL DEXTRO ASPARTIC ACID;
RACLOPRIDE;
SEROTONIN NORADRENALIN REUPTAKE INHIBITOR;
SEROTONIN UPTAKE INHIBITOR;
TACROLIMUS;
DRUG DESIGN;
DRUG DETERMINATION;
POSITRON EMISSION TOMOGRAPHY;
REVIEW;
ANIMALS;
DRUG DISCOVERY;
DRUG EVALUATION, PRECLINICAL;
HUMANS;
PHARMACOKINETICS;
POSITRON-EMISSION TOMOGRAPHY;
|
EID: 77149167307
PISSN: 00155691
EISSN: 13478397
Source Type: Journal
DOI: 10.1254/fpj.135.80 Document Type: Review |
Times cited : (1)
|
References (18)
|